LianBio (LIANY)

USD 0.17

(-12.7%)

EBITDA Summary of LianBio

  • LianBio's latest annual EBITDA in 2023 was 312.91 Million USD , up 20.92% from previous year.
  • LianBio's latest quarterly EBITDA in 2023 FY was N/A , up 20.92% from previous quarter.
  • LianBio reported an annual EBITDA of -109.48 Million USD in 2022, up 36.41% from previous year.
  • LianBio reported an annual EBITDA of -195.51 Million USD in 2021, down -44.64% from previous year.
  • LianBio reported a quarterly EBITDA of N/A for 2023 FY, up 20.92% from previous quarter.
  • LianBio reported a quarterly EBITDA of -22.12 Million USD for 2023 Q4, up 14.92% from previous quarter.

Annual EBITDA Chart of LianBio (2023 - 2019)

Historical Annual EBITDA of LianBio (2023 - 2019)

Year EBITDA EBITDA Growth
2023 312.91 Million USD 20.92%
2022 -109.48 Million USD 36.41%
2021 -195.51 Million USD -44.64%
2020 -134.9 Million USD -453.86%
2019 -24.37 Million USD 0.0%

Peer EBITDA Comparison of LianBio

Name EBITDA EBITDA Difference
Bit Brother Limited -37.57 Million USD 932.714%
Borqs Technologies, Inc. -25.3 Million USD 1336.667%
Ever-Glory International Group, Inc. 11.96 Million USD -2515.461%
SVB Financial Group 2.28 Billion USD 86.318%